On Nov. 26, CMS proposed reforms to the Medicare Advantage and Part D programs for contract year 2026, including changes to prior authorization and GLP-1 coverage. Here are 10 things ASC leaders and ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

HHS and CMS have finalized a new, mandatory model for kidney transplant coordination across 103 hospitals. The model aims to increase access, address disparities and improve care coordination for ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...

The bipartisan proposal goes further than the Transitional Coverage for Emerging Technologies (TCET) pathway that CMS is ...

The Centers for Medicare & Medicaid Services Nov. 21 announced the allocation of 200 new Medicare-funded residency slots to ...

Medicare Advantage HMOs are popular options for additional coverage not offered by Original Medicare. If you enroll in a Medicare Advantage HMO, your care will be provided by in-network providers ...